Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1146-1152

  Minami, Toshiaki ^a,b   Okuda Ashitaka, Emiko ^c   Mori, Hidemaro ^a   Ito, Seiji ^b,c   Hayaishi, Osamu ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 9BETA CHLORO 15 CYCLOHEXYL 9 DEOXY 16,17,18,19,20 PENTANORPROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SUBSTANCE P; 4 AMINOBUTYRIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; GLYCINE; HYDANTOIN DERIVATIVE; N METHYLASPARTIC ACID;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HOT PLATE TEST; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD; WAKEFULNESS;

ADRENERGIC AGONISTS; ANIMALS; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; GLYCINE; HYDANTOINS; MALE; MICE; N-METHYLASPARTATE; PAIN; PROSTAGLANDIN D2; SPINAL CORD; WAKEFULNESS;

EID: 0030302462     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. 2 as a major prostaglandin in homogenates of rat brain. Prostaglandins 14: 633-643, 1977.
2. BURKE, S. P. AND NADLER, V. J.: Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: Effects of adenosine and baclofen. J. Neurochem. 51: 1541-1551, 1988.
3. 1. Can. J. Physiol. Pharmacol. 53: 273-284, 1975.
4. 2 is noradrenergic terminal-dependent. Neurosci. Lett. 115: 253-258, 1990.
5. COLEMAN, R. A., ICENNEDY, I., HUMPHREY, P. P. A., BUNCE, K. AND LUMLEY, P.: Prostanoids and their receptors. In Comprehensive Medical Chemistry, ed. by C. Hansch, P. G. Sammes and J. B. Taylor, vol. 3, pp. 643-714, Pergamon Press, Oxford, England, 1990.
6. COLEMAN, R. A., SMITH, W. L. AND NARUMIYA, S.: International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
7. GELGOR, L. AND MITCHELL, D.: Prostanoid synthesis in the spinal cord enhances excitability of dorsal horn convergent neurones during reperfusion of ischaemic receptive fields on the rat's tail. Pain 60: 181-187, 1995.
8. GILES, H., LEFF, P., BOLOFO, M. L., KELLY, M. G. AND ROBERTSON, A. D.: The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br. J. Pharmacol. 96: 291-300, 1989.
9. 2. J. Biol. Chem. 263: 14593-14596, 1988.
10. 2. FASEB J. 5: 2575-2581, 1991.
11. HYLDEN, J. L. K. AND WILCOX, G. L.: Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
12. 2-responsive cell line from bovine embryonic trachea. Br. J. Pharmacol. 99: 13-14, 1990.
13. 2: A biochemical perspective. Prostaglandins Leukotrienes Essential Fatty Acids 37: 219-237, 1989.
14. 2 adrenoreceptors inhibit glutamate release from rat spinal cord synaptosomes. J. Neurochem. 60: 522-526, 1993.
15. MALMBERG, A. B. AND YAKSH, T. L.: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science (Wash. DC) 257: 1276-1279, 1992a.
16. MALMBERG, A. B. AND YAKSH, T. L.: Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263: 136-146, 1992b.
17. 2 binding sites in rat brain using quantitative autoradiography. Brain Res. 581: 292-298, 1992.
18. 2α in conscious mice. Pain 61: 285-290, 1995a.
19. 2-induced allodynia in conscious mice. Br. J. Pharmacol. 115: 73-76, 1995b.
20. 2 to conscious mice. Br. J. Pharmacol. 112: 735-740, 1994a.
21. 2α injected into conscious mice. Pain 57: 225-231, 1994b.
22. 2α to conscious mice. Pain 50: 223-229, 1992a.
23. 2α-induced allodynia in conscious mice. Pain Res. 7: 129-134, 1992b.
24. 2 to conscious mice. Pain 57: 217-223, 1994c.
25. 2-induced hyperalgesia in conscious mice. Brain Res. 677: 138-144, 1995.
26. B receptor binding sites in mammalian spinal cord. Synapse 1: 530-538, 1987.
27. RAMWELL, P. W., SHAW, J. E. AND JESSUP, R.: Spontaneous and evoked release of prostaglandins from frog spinal cord. Am. J. Physiol. 211: 998-1004, 1966.
28. RANGACHARI, P. K., BETTI, P.-A., PRIOR, E. T. AND ROBERTS, R. J., II: Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: An argument for a different DP receptor? J. Pharmacol. Exp. Ther. 275: 611-617, 1995.
29. 2α receptor. J. Biol. Chem. 269: 3881-3886, 1994.
30. SHIMIZU, T. AND WOLFE, L.: Arachidonic acid cascade and signal transduction. J. Neurochem. 55: 1-15, 1990.
31. 2, a neuromodulator. Proc. Natl. Acad. Sci. U.S.A. 76: 6231-6234, 1979.
32. SUN, F. F., CHAPMANN, J. P. AND MCGUIRE, J. C.: Metabolism of prostaglandin endoperoxides in animal tissue. Prostaglandins 14: 1055-1074, 1977.
33. 2α. Brain Res. 373: 81-84, 1986.
34. TAIWO, Y. O. AND LEVINE, J. D.: Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J. Neurosci. 8: 1346-1349, 1988.
35. 2-receptor. Prostaglandins 35: 855-867, 1988.
36. 2 and BW 245C activation of human platelet adenylate cyclase. Br. J. Pharmacol. 96: 301-306, 1989.
37. 2α to conscious mice. Brain Res. 510: 26-32, 1990.
38. URADE, Y., KITAHAMA, K., OHISHI, H., KANEKO, T., MIZUNO, N. AND HAYAISHI, O.: Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc. Natl. Acad. Sci. U.S.A. 90: 9070-9074, 1993.
39. 2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. J. Neurochem. 57: 167-174, 1991.
40. VESIN, M.-F., URADE, Y., HAYAISHI, O. AND DROZ, B.: Neuronal and glial prostaglandin D synthase isozymes in chick dorsal root ganglia: A light and electron microscopic immunocytochemical study. J. Neurosci. 15: 470-476, 1995.
41. WATANABE, K., URADE, Y., MÄDER, M., MURPHY, C. AND HAYAISHI, O.: Identification of β-trace as prostaglandin D synthase. Biochem. Biophys. Res. Commun. 203: 1110-1116, 1994.
42. WATANABE, YU., WATANABE, Y. AND HAYAISHI, O.: Prostaglandin bindings in the central nervous system. In Biomedical Imaging, ed. by O. Hayaishi and K. Torizuka, pp. 227-238, Academic Press, Tokyo, 1986.
43. WHITTLE, B. J. R., MONCADA, S., MULLANE, K. AND VANE, J. R.: Platelet and cardiovascular activity of hydantoin BW 245C, a potent prostaglandin analogue. Prostaglandins 25: 205-223, 1983.
44. WOOLFE, G. AND MACDONALD, A. D.: The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J. Pharmacol. Exp. Ther. 80: 300-307, 1944.
45. YAKSH, T. L.: Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid. In Acetylsalicylic Acid: New Uses for an Old Drug, ed. by H. J. M. Barett, J. Hirsh and J. F. Mustard, pp. 137-151, Raven, New York, 1982.
46. YAKSH, T. L. AND AIMONE, L.: The central pharmacology of pain transmission. In Textbook of Pain, ed. by P. D. Wall and R. Melzack, pp. 283-320, Churchill Livingstone, Edinburgh, 1989.
47. YAKSH, T. L. AND HARTY, G. J.: Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J. Pharmacol. Exp. Ther. 244: 501-507, 1988.
48. 2-receptors: Light microscopic autoradiographic location. Proc. Natl. Acad. Sci. U.S.A. 77: 1696-1700, 1980.
49. ZIMMERMANN, M.: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.